• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine chall

tetano

Editor, Senior Moderator
Cell Rep Med


. 2021 Dec 9;2(12):100465.
doi: 10.1016/j.xcrm.2021.100465. eCollection 2021 Dec 21.
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children


André G Costa-Martins[SUP] 1 2 [/SUP], Karim Mane[SUP] 3 [/SUP], Benjamin B Lindsey[SUP] 4 [/SUP], Rodrigo L T Ogava[SUP] 1 [/SUP], Ícaro Castro[SUP] 1 [/SUP], Ya Jankey Jagne[SUP] 3 [/SUP], Hadijatou J Sallah[SUP] 3 [/SUP], Edwin P Armitage[SUP] 3 [/SUP], Sheikh Jarju[SUP] 3 [/SUP], Bankole Ahadzie[SUP] 3 [/SUP], Rebecca Ellis-Watson[SUP] 5 [/SUP], John S Tregoning[SUP] 6 [/SUP], Colin D Bingle[SUP] 4 [/SUP], Debby Bogaert[SUP] 5 [/SUP], Ed Clarke[SUP] 3 [/SUP], Jose Ordovas-Montanes[SUP] 7 8 9 10 [/SUP], David Jeffries[SUP] 3 [/SUP], Beate Kampmann[SUP] 3 11 [/SUP], Helder I Nakaya[SUP] 1 2 [/SUP], Thushan I de Silva[SUP] 3 4 [/SUP]



Affiliations

Abstract

In children lacking influenza-specific adaptive immunity, upper respiratory tract innate immune responses may influence viral replication and disease outcome. We use trivalent live attenuated influenza vaccine (LAIV) as a surrogate challenge model in children aged 24-59 months to identify pre-infection mucosal transcriptomic signatures associated with subsequent viral shedding. Upregulation of interferon signaling pathways prior to LAIV is significantly associated with lower strain-specific viral loads (VLs) at days 2 and 7. Several interferon-stimulated genes are differentially expressed in children with pre-LAIV asymptomatic respiratory viral infections and negatively correlated with LAIV VLs. Upregulation of genes enriched in macrophages, neutrophils, and eosinophils is associated with lower VLs and found more commonly in children with asymptomatic viral infections. Variability in pre-infection mucosal interferon gene expression in children may impact the course of subsequent influenza infections. This variability may be due to frequent respiratory viral infections, demonstrating the potential importance of mucosal virus-virus interactions in children.

Keywords: LAIV; asymptomatic respiratory viral infection; influenza; interferon-stimulated genes; mucosal; transcriptome.
 
Back
Top Bottom